AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Use Oral Desmopressin Judiciously for Nocturia.

OB GYN News

| August 01, 2001 | FINN, ROBERT | COPYRIGHT 2001 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

ANAHEIM, CALIF. -- Oral desmopressin is useful in the treatment of nocturia in men and women, according to two studies presented at the annual meeting of the American Urological Association.

A third study indicated that the pathogenesis of the disorder in the elderly can be accounted for by a lower functional bladder capacity or an age-related increase in nocturnal urine volume.

Nevertheless, desmopressin should be used only after potential behavioral controls for nocturia have failed and after treatable causes of nocturia have been eliminated, said Dr. Jeffrey P. Weiss of the Urocenter of New York.

Dr. Weiss presented one of the studies, a randomized, placebo-controlled trial involving 146 men with nocturia, which was defined as awakening to void more than two times per night.

The proportion of patients with at least a 50% reduction in the number of voids per night was 34% for the desmopressin group and 3% for the placebo group.

Nocturnal urine output decreased significantly in the group receiving the drug, and the mean duration of the initial period of sleep in this group was 83 minutes longer than it was in the placebo group. Overall, 29 (35%) of the patients who received desmopressin got more than 5 hours of unbroken sleep, compared with only 1 patient (2%) in the placebo group.

Dr. Philip van Kerrebroeck of University Hospital, Maastricht, the Netherlands, reported on a similar study involving 142 women. Among women who received the drug, 46% had at least a 50% reduction in the number of voids, compared with 7% of those in the placebo group.

Related articles from newspapers, magazines, journals, and more
Nabi Biopharmaceuticals presents data showing patients treated with Altastaph...
News wire article from: Asia Africa Intelligence Wire October 7, 2005 700+ words
...bloodstream infections) and fever versus the placebo group. As previously reported, the treated...Altastaph group versus 14 days in the placebo group). This substantial reduction in the...Altastaph group versus two days in the placebo group) and fever (two days in the Altastaph...
Nabi Biopharmaceuticals Presents Data Showing Patients Treated with Altastaph...
Press release article from: PR Newswire October 7, 2005 700+ words
...bloodstream infections) and fever versus the placebo group. As previously reported, the treated...Altastaph group versus 14 days in the placebo group). This substantial reduction in the...Altastaph group versus two days in the placebo group) and fever (two days in the Altastaph...
Rosuvastatin trial halted early amid fears for placebo group.
Magazine article from: GP April 18, 2008 700+ words
...effective at lowering CVD risk. It is unsurprising the trial was stopped early because there is a need to protect those in the placebo group, added Dr Pittard. 'It is, however, scientifically correct and ethical to test a drug against a placebo rather than...
Paion AG, of Aachen, Germany, said it is seeking a new U.S. partner for lead...
Newspaper article from: BioWorld International November 14, 2007 700+ words
...inconclusive results reported in June from a Phase III stroke trial that yielded a greater-than-expected response in the placebo group. Paion's former partner, Forest Laboratories Inc., of New York, returned rights to the product in August. Paion later...
Journal of Urology Article Reports MacroChem Drug Induced Erection in 67-75% of...
Press release article from: PR Newswire August 26, 1999 700+ words
LEXINGTON, Mass., Aug. 26 /PRNewswire/ -- Investigators from Northwestern University Medical School have reported in the September 1999 Journal of Urology that Topiglan(TM), a topical drug under development by MacroChem Corporation (Nasdaq: MCHM), induced erection in 67 to 75 percent of impotent
Novel agent eases acute heart failure symptoms: dyspnea was improved in 53% of...
Magazine article from: Family Practice News Jancin, Bruce July 1, 2008 700+ words
CHICAGO -- It's full speed ahead for a pivotal phase III clinical trial of the novel drug rolofylline in patients with acute decompensated heart failure and renal dysfunction, on the basis of its impressive performance in a 301-patient pilot study. In the preliminary round, the selective adenosine
Accuracy of the urinary albumin to creatinine ratio as a predictor of...
Magazine article from: Journal of Clinical Pathology Lima, C.S.P. Bottini, P.V. Garlipp, C.R. Santos, A.O. Costa, F.F. Saad, S.T.O. December 1, 2002 700+ words
...cell disease. Methods: 12UA and A/C were measured in nocturnal urine collections and random morning urine samples, respectively...taken between 8:00 and 10:00 am on the morning after the nocturnal urine collections. 12UA values were considered as the gold standard...
Reports from University of Munich describe recent advances in altitude...
Newspaper article from: Biotech Week March 11, 2009 700+ words
...of 5050 m. We, measured the severity of AMS (Lake Louise Score), BNP values, nocturnal urine volume, and urine sodium concentration. Nocturnal urine volume increased from 490 +/- 90 ml at 3440 m to 1100 +/- 104 ml at 5050 m. BNP...
Vanderbilt Study Links Melatonin Excretion With Sleep Levels in Children With...
News wire article from: Ascribe Higher Education News Service November 6, 2007 700+ words
...Disorders Center. Malow presented results of the study "Nocturnal urine 6-sulfatoxymelatonin levels are related to sleep parameters...environmental factors may also play a role. CITATION: Nocturnal urine 6-sulfatoxymelatonin levels are related to sleep parameters...
Evidence based management of nocturnal enuresis. (Evidence Based Paediatrics,...
Magazine article from: British Medical Journal Evans, Jonathan HC November 17, 2001 700+ words
...scheme, either alone or with other treatments. Desmopressin is a synthetic analogue of antidiuretic hormone that reduces nocturnal urine output. It has a rapid onset of action, making it suitable for use in the short term. It can be used alone or in combination...
For more facts and information, see all results

Source: HighBeam Research, Use Oral Desmopressin Judiciously for Nocturia.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA